Mizuho Securities USA LLC Increases Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Mizuho Securities USA LLC increased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 205.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 45,637 shares of the company’s stock after purchasing an additional 30,693 shares during the quarter. Mizuho Securities USA LLC’s holdings in HCA Healthcare were worth $18,548,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. US Bancorp DE grew its holdings in shares of HCA Healthcare by 6.7% during the 1st quarter. US Bancorp DE now owns 9,127 shares of the company’s stock worth $3,044,000 after acquiring an additional 570 shares during the period. Vanguard Group Inc. lifted its position in HCA Healthcare by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock valued at $5,666,569,000 after acquiring an additional 60,304 shares during the period. Acadian Asset Management LLC increased its stake in shares of HCA Healthcare by 115.5% during the first quarter. Acadian Asset Management LLC now owns 3,372 shares of the company’s stock valued at $1,123,000 after purchasing an additional 1,807 shares in the last quarter. Ontario Teachers Pension Plan Board grew its stake in shares of HCA Healthcare by 13.4% in the 1st quarter. Ontario Teachers Pension Plan Board now owns 11,588 shares of the company’s stock worth $3,865,000 after buying an additional 1,366 shares during the last quarter. Finally, Allstate Corp purchased a new stake in shares of HCA Healthcare in the first quarter worth $212,000. 62.73% of the stock is currently owned by institutional investors.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. The trade was a 6.89 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,155 shares of company stock worth $5,608,990 over the last ninety days. Company insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Truist Financial boosted their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. KeyCorp decreased their price objective on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a report on Monday, October 28th. TD Cowen dropped their target price on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Barclays decreased their price target on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research report on Friday, November 8th. Finally, StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Five research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $385.00.

HCA Healthcare Trading Down 0.7 %

HCA stock opened at $342.96 on Friday. The firm has a market cap of $86.87 billion, a PE ratio of 15.40, a price-to-earnings-growth ratio of 1.34 and a beta of 1.68. The firm has a fifty day moving average price of $385.11 and a 200 day moving average price of $357.25. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. HCA Healthcare, Inc. has a fifty-two week low of $238.82 and a fifty-two week high of $417.14.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be given a $0.66 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.77%. HCA Healthcare’s dividend payout ratio is currently 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.